BRITTANY HERNANDEZ

Issues related to tax reform; international taxation.

General issues related to Medicare and Medicaid, including: Part D Medicare Program; Medicare Part B reimbursement; CMMI Drug Pricing Demonstration Programs; Drug Pricing; Inflation Reduction Act of 2022 (P.L.117-169) implementation.

Issues related to pharmaceutical IP, supply chain, and tariffs; Section 232 tariff investigation on branded pharmaceuticals.

FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.9260); issues related to COPD and Type One Diabetes (T1D).

Biopharmaceutical innovation and patent policy issues. Bayh-Dole march-in rights policy issues.

Issues related to health care, the Food and Drug Administration (FDA), influenza, 340B Program, drug pricing, importation of biopharmaceuticals, international pharmaceutical supply chain, TRICARE Pharmacy Program (FY2027 National Defense Authorization Act, H.R.8800/S.4784), insulin price cap, VICP Program, CICP Program, and PBM reform; vaccine schedule and vaccine safety; Type One Diabetes (T1D); Pandemic and All-Hazards Preparedness Act (PAHPA) reauthorization; S.891, Bipartisan Health Care Act; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order.

Project-based Section 8 housing; FY2027 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act (H.R.9170).

DoD funding-Congressionally Directed MS Research Program. NIH funding, FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.9260). Ensuring access to care and coverage for people living with multiple sclerosis. Healthcare research, FY2027 Department of Defense Appropriations Act (H.R.9495).

Supporting extension of Enhanced Advanced Premium Tax Credits.

Supporting established funding levels for Medicare and Medicaid and protection of Medicaid's financing structure.

CBP staffing and technology; TSA security and staffing; FAA infrastructure investing; Infrastructure Investment and Jobs Act (P.L.117-58) implementation; FAA Reauthorization Act of 2024 (P.L.118-63) implementation; H.R.1, One Big Beautiful Bill Act (P.L.119-21) implementation; H.R.3754/S.1966, Don't Miss Your Flight Act; Surface Transportation Reauthorization, H.R.8870, BUILD America 250 Act; H.R.7613, ALERT Act; FY2027 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act (H.R.9170); FY2027 Department of Homeland Security Appropriations Act (H.R.9310).

Issues related to CMMI Drug Pricing Demonstration Programs (GLOBE and GUARD Models); GENEROUS Medicaid Drug Pricing Model.

Issues related to drug pricing; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order; Section 301 tariffs.

Issues related to pandemic preparedness and strategic stockpile readiness.

Issues related to medical countermeasure and supply management.

Issues related to pandemic preparedness and strategic stockpile readiness, including state strategic stockpiles demonstration included in the PREVENT Act. Pandemic and All- Hazards Preparedness Act reauthorization.

Policies and funding related to control, command and signaling (CCS) technologies for rail applications; Surface Transportation Reauthorization, H.R.8870, BUILD America 250 Act.

Issues pertaining to the regulation of hemp products; S.3474, Cannabinoid Safety and Regulation Act; H.R.7567, Farm, Food, and National Security Act of 2026; S.5526, Agricultural Act of 2026; H.R.7212, Hemp Enforcement, Modernization, and Protection (HEMP) Act; H.R.7024/S.3686, Hemp Planting Predictability Act; H.R.10079, Beverage Regulatory Parity Act.

Education about the importance of OTC products and benefits under Medicare Advantage.

Issues related to healthcare and payment for over-the-counter drugs; General education of over-the-counter switches, including reauthorization of the Over-the-Counter Monograph Drug User Fee Act and policies impacting a Nonprescription Drug Product with an Additional Condition for Nonprescription Use.

Policies impacting the supply chain and manufacturing of over-the-counter pharmaceutical products including tariffs.

Advocacy related to infrastructure technology creating secure, autonomous freight corridors to solve supply chain logistics issues.

Tariff issues related to aluminum.

Legislative and regulatory issues impacting the beverage industry, including SNAP and dietary guidelines; H.R.7567, Farm, Food, and National Security Act of 2026; S.5526, Agricultural Act of 2026; FY2027 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (H.R.8646). Issues related to the Make America Healthy Again Commission.

Legislative and regulatory issues impacting the beverage industry, including beverage labeling.

Support affordable access to health insurance including through extension of Enhanced Advanced Premium Tax Credits.

Funding for epilepsy program research at CDC, NIH, DoD; S.494/H.R.1189, National Plan for Epilepsy Act; FY2027 Department of Defense Appropriations Act (H.R.9495); FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.9260). Support coverage of and access to all epilepsy treatments. Support PBM reform.

Issues related to Air Traffic Control Modernization.

Issues and funding related to community mental health and substance use disorder.

Issues related to price transparency and site-neutral payment reforms to reduce out-of-pocket costs for patients with blood cancer.

Issues related to reconductoring; S.3947, REWIRE Act.

Issues related to corrosion prevention; FY2027 National Defense Authorization Act (H.R.8800/S.4784); FY2027 Department of Defense Appropriations Act (H.R.9495).

Issues related to workforce development; H.R.1151/S.756, Freedom To Invest in Tomorrow's Workforce Act.

Medicare-funded Graduate Medical Education; Osteopathic Funding and Representation; H.R.2314/S.2715, FAIR Act; H.R.3885/S.3989, Community TEAMS Act of 2025; FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.9260); FY2027 National Defense Authorization Act (H.R.8800/S.4784).

Issues related to biometrics, TSA security funding and fees.

Issues related to funding and fees; FY2027 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act (H.R.9170); FY2027 Department of Homeland Security Appropriations Act (H.R.9310).

Issues related to commercial airline competitiveness, efficiency, workforce development, and infrastructure; Infrastructure Investment and Jobs Act (P.L.117-58) implementation; FAA Reauthorization Act of 2024 (P.L.118-63) implementation; National Airspace System Modernization; Air Traffic Control Modernization (H.R.1, One Big Beautiful Bill Act, P.L.119-21 implementation); sustainable aviation fuel (H.R.7567, Farm, Food, and National Security Act of 2026; S.5526, Agricultural Act of 2026); S.2503, ROTOR Act; H.R.7613, ALERT Act; PFAS (Firefighting Foam Transition and Liability).

General education to advance policies that support innovation in the medical device industry. Issues related to the coverage and reimbursement of medical devices and technology, including AI. H.R.5343, Ensuring Patient Access to Critical Breakthrough Products Act.

Policies impacting the supply chain and manufacturing of medical devices and technology including tariffs.

Policies impacting third party repair of medtech. Issues related to competitive bidding in the FY2027 National Defense Authorization Act (H.R.8800/S.4784).

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Education about non-opioid pain therapies.H.R.1227/S.475 Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act.

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Education about precision medicine.

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Education about the importance of access to non-opioid pain therapies for Medicare beneficiaries. H.R.1227/S.475 Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act.

Issues related to aviation and aerospace programs in H.R.1, One Big Beautiful Bill Act (P.L.119-21) implementation, FY2027 National Defense Authorization Act (H.R.8800/S.4784), FY2027 Department of Defense Appropriations Act (H.R.9495), and FY2027 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act (H.R.9170).

Issues related to oversight of aviation quality and safety including Congressional hearings; S.2503/H.R.6222, ROTOR Act; H.R.7613, ALERT Act.

Issues related to tax reform; international taxation.

Issues related to health care, the Food and Drug Administration (FDA), oncology coverage, mental health, opioid abuse, 340B Program, drug pricing, importation of biopharmaceuticals, international pharmaceutical supply chain, plasma therapy, step therapy, and PBM reform; Pandemic and All-Hazards Preparedness Act (PAHPA) reauthorization; S.891, Bipartisan Health Care Act; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order.

General issues related to Medicare and Medicaid, including: Part D Medicare Program; Medicare Part B reimbursement; CMMI Drug Pricing Demonstration Programs; Drug Pricing; Inflation Reduction Act of 2022 (P.L.117-169) implementation.

Support for funding of research and policy issues related to indirect costs and accessibilityof grants and contracts. FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.9260). Proposed Rule: Regulation for Federal Financial Assistance (Docket No. OMB-2026-0034; RIN 0348-AB88).

General education about the importance of support for federal funding of scientific research.

General educationand support for federal funding of medical research.

Issues related to pharmaceutical IP, supply chain, and tariffs; Section 232 tariff investigation on branded pharmaceuticals; Section 301 tariffs.

340B drug discount program; drug pricing; importation of biopharmaceuticals; direct-to-consumer (DTC) advertising; transparency; international pharmaceutical supply chain; PBM reform; TRICARE Pharmacy Program (FY2027 National Defense Authorization Act, H.R.8800/S.4784); Pandemic and All-Hazards Preparedness Act (PAHPA) reauthorization; S.891, Bipartisan Health Care Act; S.527, Prescription Pricing for the People Act of 2025; S.1040, Drug Competition Enhancement Act; S.1041, Affordable Prescriptions for Patients Act; S.1097, Interagency Patent Coordination and Improvement Act of 2025; S.1095, Stop STALLING Act; S.1096, Preserve Access to Affordable Generics and Biosimilars Act; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients; FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.9260); FY2027 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (H.R.8646); S.2658, Medication Affordability and Patent Integrity Act; S.3014, Ensuring Timely Access to Generics Act of 2025.

Biopharmaceutical innovation and patent policy issues. Bayh-Dole march-in rights policy issues.

Issues related to pharmaceutical IP, supply chain, and tariffs; Section 232 tariff investigation on branded pharmaceuticals.

Issues related to health care, the Food and Drug Administration (FDA), oncology coverage, 340B Program, drug pricing, importation of biopharmaceuticals, international pharmaceutical supply chain, TRICARE Pharmacy Program (FY2027 National Defense Authorization Act, H.R.8800/S.4784), antimicrobial resistance, VICP Program, PBM reform, vaccine schedule and vaccine safety; Pandemic and All-Hazards Preparedness Act (PAHPA) reauthorization; S.891, Bipartisan Health Care Act; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order.

Education about how to improve the quality of kidney care treatment, expand innovation, and other insurance/payment policies. Kidney Care Access Protection Act of 2025 (H.R.6214/S.2730). Restore Protections for Dialysis Patients Act (H.R.8594/S.4750).

Education about how to improve the quality of kidney care treatment and expand innovation. Modernize Medicares payment system for end-stage renal disease (ESRD). Medicare coverage and reimbursement related to dialysis. Kidney Care Access Protection Act of 2025 (H.R.6214/S.2730). Restore Protections for Dialysis Patients Act (H.R.8594/S.4750). Improving Home Dialysis Act of 2026 (H.R.8875).

General issues related to Medicare and Medicaid, including: Part D Medicare Program; CMMI Drug Pricing Demonstration Programs (GLOBE and GUARD Models); drug pricing; H.R.6130, Alzheimers Screening and Prevention (ASAP) Act of 2025.

Regulatory and legislative health care issues, including: Alzheimer's drug development; drug pricing; Pandemic and All-Hazards Preparedness Act (PAHPA) including reauthorizing priority review vouchers; pharmaceutical scheduling; TRICARE coverage issues in FY2027 National Defense Authorization Act (H.R.8800/S.4784); PBM reform; S.891, Bipartisan Health Care Act; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order.

Issues related to tax-exempt status of philanthropies.

Issues including Federal Communications Commission (FCC) reform, privacy, cybersecurity, broadband, infrastructure, and spectrum; H.R.7386, First Responder Network Authority Reauthorization Act of 2026.

Legislative issues related to mental health/severe mental illness; advocacy for Medicaid funding and housing; FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.9260).

Issues related to tax-exempt status of philanthropies.

Advocacy related to infrastructure technology creating secure, autonomous freight corridors to solve supply chain logistics issues.

Discussions regarding U.S. export promotion and efforts to increase trade and investment flows between countries in North America, Asia, and Europe (no specific legislation). Discussions regarding international economic policy issues related to trade promotion (no specific legislation). Discussions regarding efforts to strengthen economic and commercial ties between the United States and allied countries like South Korea, Taiwan, Japan, the UK, and the European Union (no specific legislation).

Issues related to price transparency and site-neutral payment reforms to reduce out-of-pocket costs for patients with blood cancer.

Issues related to the global supply chain; Ocean Shipping Reform Act of 2022 (P.L.117-146) implementation; S.1541/H.R.3151, SHIPS for America Act of 2025.

General trade related issues impacting spray foam.

Issues related to Weatherization Assistance Program updates at the Department of Energy; H.R.1355, Weatherization Enhancement and Readiness Act of 2025. Issues related to building codes.

Legislation and regulations that can impact spray foam.

General education to advance policies that support innovation in the medical device industry. Issues related to coverage and reimbursement of diagnostic tests, including issues related to FDA regulation of medical devices. Issues related to medical device sterilization. Policy issues related to the regulation of artificial intelligence for medical technology. Issues related to cybersecurity of medical devices manufactured in China. Policies that could impact supply chain for medical technology. H.R.5343, Ensuring Patient Access to Critical Breakthrough Products Act.

Policies impacting third party repair of medtech. Issues related to competitive bidding in the FY2027 National Defense Authorization Act (H.R.8800/S.4784).

General issues related to Medicare and Medicaid, including: Part D Medicare Program; Medicare Part B reimbursement; CMMI Drug Pricing Demonstration Programs; Drug Pricing; Inflation Reduction Act of 2022 (P.L.117-169) implementation.

FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.9260); issues related to COPD and Type One Diabetes (T1D).

Issues related to health care, the Food and Drug Administration (FDA), influenza, 340B Program, drug pricing, importation of biopharmaceuticals, international pharmaceutical supply chain, TRICARE Pharmacy Program (FY2027 National Defense Authorization Act, H.R.8800/S.4784), insulin price cap, VICP Program, CICP Program, and PBM reform; vaccine schedule and vaccine safety; Type One Diabetes (T1D) and military healthcare; Pandemic and All-Hazards Preparedness Act (PAHPA) reauthorization; S.891, Bipartisan Health Care Act; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order.

Project-based Section 8 housing; FY2027 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act (H.R.9170).

DoD funding-Congressionally Directed MS Research Program. NIH funding, FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.9260). Ensuring access to care and coverage for people living with multiple sclerosis. Healthcare research, FY2027 Department of Defense Appropriations Act (H.R.9495).

Supporting established funding levels for Medicare and Medicaid and protection of Medicaid's financing structure.

Supporting extension of Enhanced Advanced Premium Tax Credits.

Legislation affecting the regulation of insurance products and companies, including issues related to international capital standards for insurance, flood insurance, autonomous vehicles, cannabis-related banking, resilience policy, mortgage servicer insurance requirements, and Right to Repair. Inflation Reduction Act of 2022 (P.L.117-169) implementation. Infrastructure Investment and Jobs Act (P.L.117-58) implementation. FHFA guidance on property casualty insurance issues. HR.7128/S.4395, TRIA Program Reauthorization Act of 2026.

Issues related to tax reform; Issues related to third-party litigation funding; S.1821/H.R.3512, Tackling Predatory Litigation Funding Act; H.R.1, One Big Beautiful Bill Act (P.L.119-21) implementation.

CBP staffing and technology; TSA security and staffing; FAA infrastructure investing; Infrastructure Investment and Jobs Act (P.L.117-58) implementation; FAA Reauthorization Act of 2024 (P.L.118-63) implementation; H.R.1, One Big Beautiful Bill Act (P.L.119-21) implementation; H.R.3754/S.1966, Don't Miss Your Flight Act; Surface Transportation Reauthorization, H.R.8870, BUILD America 250 Act; H.R.7613, ALERT Act; FY2027 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act (H.R.9170); FY2027 Department of Homeland Security Appropriations Act (H.R.9310).

Issues related to pandemic preparedness and strategic stockpile readiness.

Issues related to medical countermeasure and supply management.

Issues related to pandemic preparedness and strategic stockpile readiness, including state strategic stockpiles demonstration included in the PREVENT Act. Pandemic and All- Hazards Preparedness Act reauthorization.

Policies and funding related to control, command and signaling (CCS) technologies for rail applications; Surface Transportation Reauthorization, H.R.8870, BUILD America 250 Act.

Issues pertaining to the regulation of hemp products; S.3474, Cannabinoid Safety and Regulation Act; H.R.7567, Farm, Food, and National Security Act of 2026; H.R.7212, Hemp Enforcement, Modernization, and Protection (HEMP) Act; H.R.7024/S.3686, Hemp Planting Predictability Act.

Education about the importance of OTC products and benefits under Medicare Advantage.

Policies impacting the supply chain and manufacturing of over-the-counter pharmaceutical products including tariffs.

Policies impacting access to over-the-counter products; FY2027 Financial Services and General Government Appropriations Act (H.R.8495).

Legislative issues related to mental health/severe mental illness; advocacy for Medicaid funding and housing; FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.9260).

Funding for epilepsy program research at CDC, NIH, DoD; S.494/H.R.1189, National Plan for Epilepsy Act; FY2027 Department of Defense Appropriations Act (H.R.9495); FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.9260). Support coverage of and access to all epilepsy treatments. Support PBM reform.

Support affordable access to health insurance including through extension of Enhanced Advanced Premium Tax Credits.

Legislative and regulatory issues impacting the beverage industry, including SNAP and dietary guidelines; H.R.7567, Farm, Food, and National Security Act of 2026; FY2027 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (H.R.8646). Issues related to the Make America Healthy Again Commission.

Legislative and regulatory issues impacting the beverage industry, including beverage labeling.

Issues related to Air Traffic Control Modernization.

Issues and funding related to community mental health and substance use disorder.

Issues related to pharmaceutical IP, supply chain, and tariffs; Section 232 tariff investigation on branded pharmaceuticals; Section 301 tariffs.

General issues related to Medicare and Medicaid, including: Part D Medicare Program; Medicare Part B reimbursement; noninterference; CMMI Drug Pricing Demonstration Programs; drug pricing; Valued-Based Payments; H.R.1492/S.832, EPIC Act of 2025; Inflation Reduction Act of 2022 (P.L.117-169) implementation.

Biopharmaceutical innovation and patent policy issues. Bayh-Dole march-in rights policy issues.

Issues related to corrosion prevention; FY2027 National Defense Authorization Act (H.R.8800/S.4784); FY2027 Department of Defense Appropriations Act (H.R.9495).

Issues related to transportation infrastructure safety and maintenance, water infrastructure, corrosion prevention, and pipeline maintenance; H.R.4170, Bridge Corrosion Prevention and Repair Act of 2025; H.R.2613, Next Generation Pipelines Research and Development Act; H.R.8870, BUILD America 250 Act. Issues related to shipbuilding including S.1541/H.R.3151, SHIPS for America Act of 2025.

Medicare-funded Graduate Medical Education; Osteopathic Funding and Representation; H.R.2314/S.2715, FAIR Act; H.R.3885/S.3989, Community TEAMS Act of 2025; FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.9260); FY2027 National Defense Authorization Act (H.R.8800/S.4784).

Issues related to biometrics, TSA security funding and fees.

Issues related to funding and fees; FY2027 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act (H.R.9170); FY2027 Department of Homeland Security Appropriations Act (H.R.9310).

Issues related to commercial airline competitiveness, efficiency, workforce development, and infrastructure; Infrastructure Investment and Jobs Act (P.L.117-58) implementation; FAA Reauthorization Act of 2024 (P.L.118-63) implementation; National Airspace System Modernization; Air Traffic Control Modernization (H.R.1, One Big Beautiful Bill Act, P.L.119-21 implementation); sustainable aviation fuel (H.R.7567, Farm, Food, and National Security Act of 2026); S.2503, ROTOR Act; H.R.7613, ALERT Act; PFAS (Firefighting Foam Transition and Liability).

Issues related to aviation and aerospace programs in H.R.1, One Big Beautiful Bill Act (P.L.119-21) implementation, FY2027 National Defense Authorization Act (H.R.8800/S.4784), FY2027 Department of Defense Appropriations Act (H.R.9495), and FY2027 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act (H.R.9170).

Issues related to oversight of aviation quality and safety including Congressional hearings; S.2503/H.R.6222, ROTOR Act; H.R.7613, ALERT Act.

Issues related to health care, the Food and Drug Administration (FDA), oncology coverage, mental health, opioid abuse, 340B Program, drug pricing, importation of biopharmaceuticals, international pharmaceutical supply chain, plasma therapy, step therapy, and PBM reform; Pandemic and All-Hazards Preparedness Act (PAHPA) reauthorization; S.891, Bipartisan Health Care Act; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order.

General issues related to Medicare and Medicaid, including: Part D Medicare Program; Medicare Part B reimbursement; CMMI Drug Pricing Demonstration Programs; Drug Pricing; Inflation Reduction Act of 2022 (P.L.117-169) implementation.

General educationand support for federal funding of medical research.

Support for funding of research and policy issues related to indirect costs and accessibilityof grants and contracts. FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.9260). Proposed Rule: Regulation for Federal Financial Assistance (Docket No. OMB-2026-0034; RIN 0348-AB88).

General education about the importance of support for federal funding of scientific research.

Issues related to health care, the Food and Drug Administration (FDA), oncology coverage, 340B Program, drug pricing, importation of biopharmaceuticals, international pharmaceutical supply chain, TRICARE Pharmacy Program (FY2027 National Defense Authorization Act, H.R.8800/S.4784), antimicrobial resistance, VICP Program, PBM reform, vaccine schedule and vaccine safety; Pandemic and All-Hazards Preparedness Act (PAHPA) reauthorization; S.891, Bipartisan Health Care Act; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order.

Issues related to tax reform; R&D tax credit; international taxation; H.R.1, One Big Beautiful Bill Act (P.L.119-21) implementation.

Education about how to improve the quality of kidney care treatment, expand innovation, and other insurance/payment policies. Kidney Care Access Protection Act of 2025 (H.R.6214/S.2730). Restore Protections for Dialysis Patients Act (H.R.8594/S.4750).

Education about how to improve the quality of kidney care treatment and expand innovation. Modernize Medicares payment system for end-stage renal disease (ESRD). Medicare coverage and reimbursement related to dialysis. Kidney Care Access Protection Act of 2025 (H.R.6214/S.2730). Restore Protections for Dialysis Patients Act (H.R.8594/S.4750). Improving Home Dialysis Act of 2026 (H.R.8875).

General education about biomedical research and support for scientific funding. Policies to advance AI supported long-term, population-scale health studies and accelerate translation of research findings to treatments. Education and awareness regarding genetic medicines for rare and ultra-rare diseases.

Federal funding for research and policy issues related to biomarkers and stress biology, including potential applications in defense and human performance.FY2027 National Defense Authorization Act (H.R.8800/S.4784) and FY2027 Department of Defense Appropriations Act (H.R.9495). Education and discussion regarding Broad Institute capabilities and technologies relevant to national biological intelligence, biosurveillance, and reconnaissance (ISR).

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Education about precision medicine.

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Education about the importance of access to non-opioid pain therapies for Medicare beneficiaries. H.R.1227/S.475 Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act.

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Education about non-opioid pain therapies.H.R.1227/S.475 Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act.

Education related to intermodal transportation and the development of autonomous battery-electric rail vehicle; Infrastructure Investment and Jobs Act (P.L.117-58) implementation; FY2027 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act (H.R.9170); Surface Transportation Reauthorization, H.R.8870, BUILD America 250 Act; H.R.928, Railway Safety Act of 2025.

Issues related to supply chain and tariffs; Section 232 tariff investigation on branded pharmaceuticals.

Regulatory and legislative health care issues, including: Alzheimer's drug development; drug pricing; Pandemic and All-Hazards Preparedness Act (PAHPA) including reauthorizing priority review vouchers; pharmaceutical scheduling; TRICARE coverage issues in FY2027 National Defense Authorization Act (H.R.8800/S.4784); PBM reform; S.891, Bipartisan Health Care Act; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order.

General issues related to Medicare and Medicaid, including: Part D Medicare Program; CMMI Drug Pricing Demonstration Programs (GLOBE and GUARD Models); drug pricing.

Issues including Federal Communications Commission (FCC) reform, privacy, cybersecurity, broadband, infrastructure, and spectrum; H.R.7386, First Responder Network Authority Reauthorization Act of 2026.

Advocacy related to infrastructure technology creating secure, autonomous freight corridors to solve supply chain logistics issues.

Advocacy for site-neutral payment reforms to reduce out-of-pocket costs for patients with blood cancer.

Federal policies and funding related to geothermal energy infrastructure.

Federal policies and funding related to geothermal energy infrastructure.

Education about how to improve the quality of kidney care treatment and expand innovation. Kidney Care Access Protection Act of 2025 (H.R.6214/S.2730). Restore Protections for Dialysis Patients Act (H.R.8594/S.4750).

Education about how to improve the quality of kidney care treatment and expand innovation. Kidney Care Access Protection Act of 2025 (H.R.6214/S.2730). Restore Protections for Dialysis Patients Act (H.R.8594/S.4750).

Issues related to the rescissions package; FY2026 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.5304/S.2587); FY2026 Continuing Appropriations and Extensions Act (H.R.5371/P.L.119-37).

Discussions regarding U.S. export promotion and efforts to increase trade and investment flows between countries in North America, Asia, and Europe (no specific legislation). Discussions regarding international economic policy issues related to trade promotion (no specific legislation). Discussions regarding efforts to strengthen economic and commercial ties between the United States and allied countries like South Korea, Taiwan, Japan, the UK, and the European Union (no specific legislation).

Policies and funding related to control, command and signaling (CCS) technologies for rail applications.

General educationand support for federal funding of medical research.

General education about the importance of support for federal funding of scientific research.

Support for funding of research and policy issues related to indirect costs and accessibilityof grants and contracts. FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations.

Support affordable access to health insurance including through extension of Enhanced Advanced Premium Tax Credits.

Funding for epilepsy program research at CDC, NIH, DoD; S.494/H.R.1189, National Plan for Epilepsy Act; FY2027 Department of Defense Appropriations; FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. Support coverage of and access to all epilepsy treatments. Support PBM reform.

General issues related to Medicare and Medicaid, including: Part D Medicare Program; Medicare Part B reimbursement; CMMI Drug Pricing Demonstration Programs; Drug Pricing; Inflation Reduction Act of 2022 (P.L.117-169) implementation.

Issues related to pharmaceutical IP, supply chain, and tariffs; Section 232 tariff investigation on branded pharmaceuticals.

Issues related to health care, the Food and Drug Administration (FDA), oncology coverage, 340B Program, drug pricing, importation of biopharmaceuticals, international pharmaceutical supply chain, TRICARE Pharmacy Program (FY2027 National Defense Authorization Act), antimicrobial resistance, VICP Program, PBM reform, vaccine schedule and vaccine safety; Pandemic and All-Hazards Preparedness Act (PAHPA) reauthorization; S.891, Bipartisan Health Care Act; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order.

Issues pertaining to the regulation of hemp products; S.3474, Cannabinoid Safety and Regulation Act; H.R.7567, Farm, Food, and National Security Act of 2026; H.R.7212, Hemp Enforcement, Modernization, and Protection (HEMP) Act; H.R.7024/S.3686, Hemp Planting Predictability Act.

Supporting extension of Enhanced Advanced Premium Tax Credits.

Supporting established funding levels for Medicare and Medicaid and protection of Medicaid's financing structure.

DoD funding-Congressionally Directed MS Research Program. NIH funding, FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. Ensuring access to care and coverage for people living with multiple sclerosis. Healthcare research, FY2027 Department of Defense Appropriations.

Issues and funding related to community mental health and substance use disorder.

Issues related to Air Traffic Control Modernization.

Legislative and regulatory issues impacting the beverage industry, including beverage labeling.

Legislative and regulatory issues impacting the beverage industry, including SNAP in H.R.7567, Farm, Food, and National Security Act of 2026, and dietary guidelines. Issues related to the Make America Healthy Again Commission.

General education about biomedical research and support for scientific funding. Policies to advance AI supported long-term, population-scale health studies and accelerate translation of research findings to treatments.

Federal funding for research and policy issues related to biomarkers and stress biology, including potential applications in defense and human performance.FY2027 National Defense Authorization Act and FY2027 Department of Defense Appropriations.

General education about biomedical research and support for scientific funding. Policies to advance AI supported long-term, population-scale health studies and accelerate translation of research findings to treatments.

Issues related to Weatherization Assistance Program updates at the Department of Energy; H.R.1355, Weatherization Enhancement and Readiness Act of 2025. Issues related to building codes.

Building efficiency projects or studies that encourage the use of spray foam in annual federal appropriations bills; FY2026 Energy and Water Development and Related Agencies Appropriations Act (H.R.4553/S.3293); H.R.6938, Making consolidated appropriations for the fiscal year ending September 30, 2026, and for other purposes (P.L.119-74) implementation.

General trade related issues impacting spray foam.

Medicare-funded Graduate Medical Education; Osteopathic Funding and Representation; H.R.2314/S.2715, FAIR Act; H.R.3885/S.3989, Community TEAMS Act of 2025; FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations; FY2027 National Defense Authorization Act.

Education about the importance of OTC products and benefits under Medicare Advantage.

Policies impacting access to over-the-counter products; FY2026 Financial Services and General Government Appropriations Act process (H.R.5166/S.3290); H.R.7148, Making further consolidated appropriations for the fiscal year ending September 30, 2026, and for other purposes (P.L.119-75).

Policies impacting the supply chain and manufacturing of over-the-counter pharmaceutical products including tariffs.

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Education about the importance of access to non-opioid pain therapies for Medicare beneficiaries. H.R.1227/S.475 Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act.

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Education about non-opioid pain therapies.H.R.1227/S.475 Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act.

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Education about precision medicine.

Issues related to pandemic preparedness and strategic stockpile readiness, including funding for state strategic stockpiles demonstration included in the PREVENT Act; FY2026 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.5304/S.2587); H.R.7148, Making further consolidated appropriations for the fiscal year ending September 30, 2026, and for other purposes (P.L.119-75); FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations.

Issues related to pandemic preparedness and strategic stockpile readiness, including state strategic stockpiles demonstration included in the PREVENT Act. Pandemic and All- Hazards Preparedness Act reauthorization.

Issues related to corrosion prevention; FY2027 National Defense Authorization Act; FY2027 Department of Defense Appropriations.

Issues related to transportation infrastructure safety and maintenance, water infrastructure, corrosion prevention, and pipeline maintenance; H.R.4170, Bridge Corrosion Prevention and Repair Act of 2025; H.R.2613, Next Generation Pipelines Research and Development Act. Issues related to shipbuilding including S.1541/H.R.3151, SHIPS for America Act of 2025.

Issues related to workforce development; H.R.1151/S.756, Freedom To Invest in Tomorrow's Workforce Act.

CBP staffing and technology; TSA security and staffing; FAA infrastructure investing; Infrastructure Investment and Jobs Act (P.L.117-58) implementation; FAA Reauthorization Act of 2024 (P.L.118-63) implementation; H.R.1, One Big Beautiful Bill Act (P.L.119-21) implementation; H.R.3754/S.1966, Don't Miss Your Flight Act; Surface Transportation Reauthorization; FY2026 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act (H.R.4552/S.2465); FY2027 Transportation, Housing and Urban Development, and Related Agencies Appropriations; FY2026 Department of Homeland Security Appropriations Act (H.R.4213); H.R.7613, ALERT Act.

Project-based Section 8 housing; FY2026 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act (H.R.4552/S.2465); H.R.7148, Making further consolidated appropriations for the fiscal year ending September 30, 2026, and for other purposes (P.L.119-75).

Issues related to oversight of aviation quality and safety including Congressional hearings; S.2503/H.R.6222, ROTOR Act; H.R.7613, ALERT Act.

Issues related to aviation and aerospace programs in FY2026 Department of Defense Appropriations Act (H.R.4016/S.2572), FY2026 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act (H.R.4552/S.2465), H.R.1, One Big Beautiful Bill Act (P.L.119-21) implementation, H.R.7148, Making further consolidated appropriations for the fiscal year ending September 30, 2026, and for other purposes (P.L.119-75), FY2027 National Defense Authorization Act, FY2027 Department of Defense Appropriations, and FY2027 Transportation, Housing and Urban Development, and Related Agencies Appropriations.

Education related to intermodal transportation and the development of autonomous battery-electric rail vehicle; Infrastructure Investment and Jobs Act (P.L.117-58) implementation; FY2026 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act (H.R.4552/S.2465); H.R.7148, Making further consolidated appropriations for the fiscal year ending September 30, 2026, and for other purposes (P.L.119-75); FY2027 Transportation, Housing and Urban Development, and Related Agencies Appropriations; Surface Transportation Reauthorization; H.R.928, Railway Safety Act of 2025.

Legislative issues related to mental health/severe mental illness; advocacy for Medicaid funding and housing; FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations.

Issues related to the global supply chain; Ocean Shipping Reform Act of 2022 (P.L.117-146) implementation; S.1541/H.R.3151, SHIPS for America Act of 2025.

Issues related to tax reform; R&D tax credit; international taxation; Section 899; H.R.1, One Big Beautiful Bill Act (P.L.119-21) implementation.

Issues related to pharmaceutical IP, supply chain, and tariffs; Section 232 tariff investigation on branded pharmaceuticals.

General issues related to Medicare and Medicaid, including: Part D Medicare Program; Medicare Part B reimbursement; CMMI Drug Pricing Demonstration Programs; Drug Pricing; Inflation Reduction Act of 2022 (P.L.117-169) implementation.

General issues related to Medicare and Medicaid, including: Part D Medicare Program; Medicare Part B reimbursement; noninterference; CMMI Drug Pricing Demonstration Programs; drug pricing; Valued-Based Payments; H.R.1492/S.832, EPIC Act of 2025; Inflation Reduction Act of 2022 (P.L.117-169) implementation.

340B drug discount program; drug pricing; importation of biopharmaceuticals; direct-to-consumer (DTC) advertising; transparency; international pharmaceutical supply chain; PBM reform; TRICARE Pharmacy Program (FY2027 National Defense Authorization Act); Pandemic and All-Hazards Preparedness Act (PAHPA) reauthorization; S.891, Bipartisan Health Care Act; S.527, Prescription Pricing for the People Act of 2025; S.1040, Drug Competition Enhancement Act; S.1041, Affordable Prescriptions for Patients Act; S.1097, Interagency Patent Coordination and Improvement Act of 2025; S.1095, Stop STALLING Act; S.1096, Preserve Access to Affordable Generics and Biosimilars Act; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients; FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations; FY2027 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations.

Issues related to biometrics, TSA security funding and fees.

Issues related to funding and fees; FY2026 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act (H.R.4552/S.2465); FY2026 Department of Homeland Security Appropriations Act (H.R.4213); H.R.7148, Making further consolidated appropriations for the fiscal year ending September 30, 2026, and for other purposes (P.L.119-75); FY2027 Transportation, Housing and Urban Development, and Related Agencies Appropriations.

Issues related to commercial airline competitiveness, efficiency, workforce development, and infrastructure; Infrastructure Investment and Jobs Act (P.L.117-58) implementation; FAA Reauthorization Act of 2024 (P.L.118-63) implementation; National Airspace System Modernization; Air Traffic Control Modernization (H.R.1, One Big Beautiful Bill Act, P.L.119-21 implementation); sustainable aviation fuel (H.R.7567, Farm, Food, and National Security Act of 2026); S.2503, ROTOR Act; H.R.7613, ALERT Act; PFAS (Firefighting Foam Transition and Liability).